Godsey & Gibb Inc’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.18K | Hold |
133
| – | – | ﹤0.01% | 262 |
|
|
2025
Q1 | $9.24K | Hold |
133
| – | – | ﹤0.01% | 285 |
|
|
2024
Q4 | $11.4K | Sell |
133
-507
| -79% | -$43.6K | ﹤0.01% | 263 |
|
|
2024
Q3 | $76.2K | Buy |
640
+375
| +142% | +$44.7K | 0.01% | 154 |
|
|
2024
Q2 | $37.8K | Sell |
265
-265
| -50% | -$37.8K | ﹤0.01% | 209 |
|
|
2024
Q1 | $68.1K | Sell |
530
-60
| -10% | -$7.7K | 0.01% | 146 |
|
|
2023
Q4 | $61K | Hold |
590
| – | – | 0.01% | 147 |
|
|
2023
Q3 | $53.7K | Sell |
590
-30
| -5% | -$2.73K | 0.01% | 152 |
|
|
2023
Q2 | $50.2K | Hold |
620
| – | – | 0.01% | 167 |
|
|
2023
Q1 | $49.3K | Sell |
620
-40
| -6% | -$3.18K | 0.01% | 166 |
|
|
2022
Q4 | $44.7K | Buy |
+660
| New | +$44.7K | 0.01% | 126 |
|
|
2022
Q1 | – | Sell |
-660
| Closed | -$37K | – | 135 |
|
|
2021
Q4 | $37K | Buy |
+660
| New | +$37K | 0.01% | 59 |
|
|
2021
Q3 | – | Sell |
-1,320
| Closed | -$55K | – | 120 |
|
|
2021
Q2 | $55K | Buy |
+1,320
| New | +$55K | 0.03% | 41 |
|